ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations.

European Working Group for Breast Screening Pathology ONEST TILs breast cancer international immuno-oncology biomarker working group observers needed to evaluate subjective tests reproducibility sTILs triple-negative tumour-infiltrating lymphocytes

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
14 Feb 2023
Historique:
received: 20 01 2023
revised: 04 02 2023
accepted: 09 02 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 26 2 2023
Statut: epublish

Résumé

Tumour-infiltrating lymphocytes (TILs) reflect antitumour immunity. Their evaluation of histopathology specimens is influenced by several factors and is subject to issues of reproducibility. ONEST (Observers Needed to Evaluate Subjective Tests) helps in determining the number of observers that would be sufficient for the reliable estimation of inter-observer agreement of TIL categorisation. This has not been explored previously in relation to TILs. ONEST analyses, using an open-source software developed by the first author, were performed on TIL quantification in breast cancers taken from two previous studies. These were one reproducibility study involving 49 breast cancers, 23 in the first circulation and 14 pathologists in the second circulation, and one study involving 100 cases and 9 pathologists. In addition to the estimates of the number of observers required, other factors influencing the results of ONEST were examined. The analyses reveal that between six and nine observers (range 2-11) are most commonly needed to give a robust estimate of reproducibility. In addition, the number and experience of observers, the distribution of values around or away from the extremes, and outliers in the classification also influence the results. Due to the simplicity and the potentially relevant information it may give, we propose ONEST to be a part of new reproducibility analyses.

Identifiants

pubmed: 36831541
pii: cancers15041199
doi: 10.3390/cancers15041199
pmc: PMC9954449
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Mod Pathol. 2020 Sep;33(9):1746-1752
pubmed: 32300181
Pathol Oncol Res. 2022 Jun 27;28:1610373
pubmed: 35845921
J Clin Oncol. 2014 Sep 20;32(27):2959-66
pubmed: 25071121
NPJ Breast Cancer. 2021 Dec 1;7(1):150
pubmed: 34853355
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
Am J Clin Pathol. 2018 Oct 01;150(5):441-450
pubmed: 30052720
J Clin Oncol. 2019 Mar 1;37(7):559-569
pubmed: 30650045
Mod Pathol. 2016 Oct;29(10):1155-64
pubmed: 27363491
Indian J Pathol Microbiol. 2018 Apr-Jun;61(2):181-186
pubmed: 29676353
Ann Diagn Pathol. 2018 Aug;35:77-79
pubmed: 29886396
Lancet Oncol. 2018 Jan;19(1):40-50
pubmed: 29233559
Cancers (Basel). 2021 Aug 31;13(17):
pubmed: 34503219
Acta Oncol. 2018 Jan;57(1):90-94
pubmed: 29168428
Ann Surg Oncol. 2016 Jul;23(7):2242-8
pubmed: 26965699
Ann Oncol. 2015 Feb;26(2):259-71
pubmed: 25214542
Mod Pathol. 2021 Dec;34(12):2130-2140
pubmed: 34218258
Virchows Arch. 2021 Dec;479(6):1101-1109
pubmed: 34415429
Semin Cancer Biol. 2018 Oct;52(Pt 2):16-25
pubmed: 29024776
Ann Oncol. 2014 Aug;25(8):1544-50
pubmed: 24608200
Mod Pathol. 2017 Sep;30(9):1204-1212
pubmed: 28621322
Breast Cancer Res Treat. 2018 Aug;171(1):1-9
pubmed: 29774470
J Immunother Cancer. 2016 Oct 18;4:59
pubmed: 27777769
Pathol Res Pract. 2022 Jan;229:153718
pubmed: 34920295
NPJ Breast Cancer. 2020 May 12;6:17
pubmed: 32411819
Anticancer Res. 2021 Apr;41(4):2133-2140
pubmed: 33813424
Magy Onkol. 2020 Dec 14;64(4):301-328
pubmed: 33313608
J Natl Cancer Inst. 2019 Aug 1;111(8):867-871
pubmed: 30888406
Virchows Arch. 2022 Jan;480(1):147-162
pubmed: 35043236
Pol J Pathol. 2019;70(2):139-143
pubmed: 31556565

Auteurs

Bálint Cserni (B)

TNG Technology Consulting GmbH, Király u. 26., 1061 Budapest, Hungary.

Darren Kilmartin (D)

Discipline of Pathology, Lambe Institute for Translational Research, School of Medicine, University of Galway, H91 TK33 Galway, Ireland.

Mark O'Loughlin (M)

Discipline of Pathology, Lambe Institute for Translational Research, School of Medicine, University of Galway, H91 TK33 Galway, Ireland.

Xavier Andreu (X)

Pathology Department, Atryshealth Co., Ltd., 08039 Barcelona, Spain.

Zsuzsanna Bagó-Horváth (Z)

Department of Pathology, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.

Simonetta Bianchi (S)

Division of Pathological Anatomy, Department of Health Sciences, University of Florence, 50134 Florence, Italy.

Ewa Chmielik (E)

Tumor Pathology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.

Paulo Figueiredo (P)

Laboratório de Anatomia Patológica, IPO Coimbra, 3000-075 Coimbra, Portugal.

Giuseppe Floris (G)

Laboratory of Translational Cell & Tissue Research and KU Leuven, Department of Imaging and Pathology, Department of Pathology, University Hospitals Leuven, University of Leuven, Oude Market 13, 3000 Leuven, Belgium.

Maria Pia Foschini (MP)

Unit of Anatomic Pathology, Department of Biomedical and Neuromotor Sciences, University of Bologna, Bellaria Hospital, 40139 Bologna, Italy.

Anikó Kovács (A)

Department of Clinical Pathology, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden.

Päivi Heikkilä (P)

Department of Pathology, Helsinki University Central Hospital, 00029 Helsinki, Finland.

Janina Kulka (J)

Department of Pathology, Forensic and Insurance Medicine, Semmelweis University Budapest, Üllői út 93, 1091 Budapest, Hungary.

Anne-Vibeke Laenkholm (AV)

Department of Surgical Pathology, Zealand University Hospital, 4000 Roskilde, Denmark.

Inta Liepniece-Karele (I)

Department of Pathology, Riga Stradins University, Riga East Clinical University Hospital, LV-1038 Riga, Latvia.

Caterina Marchiò (C)

Unit of Pathology, Candiolo Cancer Institute FPO-IRCCS, 10060 Candiolo, Italy.
Department of Medical Sciences, University of Turin, 10126 Turin, Italy.

Elena Provenzano (E)

Department of Histopathology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge CB2 0QQ, UK.
National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK.

Peter Regitnig (P)

Diagnostic and Research Institute of Pathology, Medical University of Graz, 8010 Graz, Austria.

Angelika Reiner (A)

Department of Pathology, Klinikum Donaustadt, 1090 Vienna, Austria.

Aleš Ryška (A)

The Fingerland Department of Pathology, Charles University Medical Faculty and University Hospital, 50003 Hradec Kralove, Czech Republic.

Anna Sapino (A)

Unit of Pathology, Candiolo Cancer Institute FPO-IRCCS, 10060 Candiolo, Italy.
Department of Medical Sciences, University of Turin, 10126 Turin, Italy.

Elisabeth Specht Stovgaard (ES)

Pathology Department, Herlev University Hospital, DK-2730 Herlev, Denmark.

Cecily Quinn (C)

Department of Histopathology, Irish National Breast Screening Programme, BreastCheck, St. Vincent's University Hospital and School of Medicine, University College Dublin, D04 T6F4 Dublin, Ireland.
School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland.

Vasiliki Zolota (V)

Department of Pathology, School of Medicine, University of Patras, 26504 Rion, Greece.

Mark Webber (M)

Discipline of Pathology, Lambe Institute for Translational Research, School of Medicine, University of Galway, H91 TK33 Galway, Ireland.

Sharon A Glynn (SA)

Discipline of Pathology, Lambe Institute for Translational Research, School of Medicine, University of Galway, H91 TK33 Galway, Ireland.

Rita Bori (R)

Department of Pathology, Bács-Kiskun County Teaching Hospital, 6000 Kecskemét, Hungary.

Erika Csörgő (E)

Department of Pathology, Bács-Kiskun County Teaching Hospital, 6000 Kecskemét, Hungary.

Orsolya Oláh-Németh (O)

Department of Pathology, University of Szeged, 6720 Szeged, Hungary.

Tamás Pancsa (T)

Department of Pathology, University of Szeged, 6720 Szeged, Hungary.

Anita Sejben (A)

Department of Pathology, University of Szeged, 6720 Szeged, Hungary.

István Sejben (I)

Department of Pathology, Bács-Kiskun County Teaching Hospital, 6000 Kecskemét, Hungary.

András Vörös (A)

Department of Pathology, University of Szeged, 6720 Szeged, Hungary.

Tamás Zombori (T)

Department of Pathology, University of Szeged, 6720 Szeged, Hungary.

Tibor Nyári (T)

Department of Medical Physics and Informatics, University of Szeged, 6720 Szeged, Hungary.

Grace Callagy (G)

Discipline of Pathology, Lambe Institute for Translational Research, School of Medicine, University of Galway, H91 TK33 Galway, Ireland.

Gábor Cserni (G)

Department of Pathology, Bács-Kiskun County Teaching Hospital, 6000 Kecskemét, Hungary.
Department of Pathology, University of Szeged, 6720 Szeged, Hungary.

Classifications MeSH